XBIT
XBiotech Inc
NASDAQ: XBIT · HEALTHCARE · BIOTECHNOLOGY
$2.57
+1.98% today
Updated 2026-04-30
Market cap
$77.44M
P/E ratio
—
P/S ratio
12.23x
EPS (TTM)
$-1.49
Dividend yield
—
52W range
$2 – $4
Volume
0.0M
XBiotech Inc (XBIT) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-11.63M | $-8.91M | $-11.70M | $-33.31M | $-46.02M | $-33.65M | $-16.54M | $-18.27M | $-65.15M | $69.44M | $-14.82M | $-18.73M | $-30.96M | $-39.92M |
| Capital expenditures | $550000.00 | $59000.00 | $1.40M | $10.39M | $13.91M | $1.41M | $122000.00 | $204000.00 | $3.73M | $3.52M | $585000.00 | $362000.00 | $1.30M | $289000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $2.82M | $739000.00 | $7.02M | $4.41M | $5.57M | $1.75M | $1.66M | $3.36M | $12.58M | $4.46M | $5.06M | $3.26M | $1.75M | $3.62M |
| Free cash flow | $-12.18M | $-8.97M | $-13.10M | $-43.70M | $-59.93M | $-35.05M | $-16.66M | $-18.47M | $-68.88M | $65.92M | $-15.41M | $-19.09M | $-32.27M | $-40.21M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | $0.00 | $0.00 | $0.00 | $75.00M | $75.00M | $75.00M | $75.00M | $0.00 | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $33.72M | $-56.73M | $-2.56M | $-15.95M | $698.77M | $-478.60M | $-1.09M | $-78.72M | — | — | — |